ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2013

3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.

Eliot T McKinley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.